My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
About Us
Plans & Pricing
Welcome

Analysts Offer Insights on Healthcare Companies: Hill-Rom (HRC), AstraZeneca (AZN) and Pfizer (PFE)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hill-Rom (HRCResearch Report), AstraZeneca (AZNResearch Report) and Pfizer (PFEResearch Report).

Hill-Rom (HRC)

Morgan Stanley analyst Drew Ranieri downgraded Hill-Rom to Hold today and set a price target of $156.00. The company’s shares closed last Friday at $150.50, close to its 52-week high of $152.37.

According to TipRanks.com, Ranieri is a 2-star analyst with an average return of 3.5% and a 53.8% success rate. Ranieri covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Intuitive Surgical, and Avanos Medical.

Hill-Rom has an analyst consensus of Hold, with a price target consensus of $149.25, representing a -0.9% downside. In a report issued on September 7, KeyBanc also downgraded the stock to Hold.

See today’s analyst top recommended stocks >>

AstraZeneca (AZN)

Leerink Partners analyst Andrew Berens maintained a Buy rating on AstraZeneca today and set a price target of $71.00. The company’s shares closed last Friday at $55.56.

According to TipRanks.com, Berens is a 4-star analyst with an average return of 8.8% and a 60.6% success rate. Berens covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Turning Point Therapeutics, and Zentalis Pharmaceuticals.

AstraZeneca has an analyst consensus of Strong Buy, with a price target consensus of $69.63.

Pfizer (PFE)

Leerink Partners analyst Geoff Porges maintained a Hold rating on Pfizer today and set a price target of $50.00. The company’s shares closed last Friday at $43.89.

According to TipRanks.com, Porges is a 3-star analyst with an average return of 2.9% and a 49.1% success rate. Porges covers the Healthcare sector, focusing on stocks such as Opthea Limited Sponsored ADR, Vertex Pharmaceuticals, and Theravance Biopharma.

Pfizer has an analyst consensus of Hold, with a price target consensus of $45.55, a 3.1% upside from current levels. In a report issued on September 13, J.P. Morgan also maintained a Hold rating on the stock with a $42.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on HRC: